This review contrasts the standard of care for focal epilepsy with the complex reality of managing non-lesional and drug-resistant cases.

January 8, 2010 — An experimental light therapy is being investigated as an alternative to antiepileptic drugs or surgery for focal seizures. Researchers suggest that a small UV-emitting diode might ...

Please provide your email address to receive an email when new articles are posted on . Cannabidiol treatment was associated with median reduction of 67% to 99% in focal aware seizures. All ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Two stress-reducing behavioral interventions may be effective in reducing seizures in adult patients with medication-resistant focal epilepsy, new research suggests. In a randomized trial of 64 ...

In a first-in-humans pilot study, researchers have identified a sentinel area of the brain that may give an early warning before clinical seizure manifestations from focal epilepsy appear. They have ...

Having subtler symptoms, a form of epilepsy that affects only one part of the brain often goes undiagnosed long enough to cause unexpected seizures that contribute to car crashes, a new study finds.

University of California San Diego is conducting new, Phase 2/3 national epilepsy clinical research trials, called Rise, to study BHV-7000, a novel investigational therapy, in focal epilepsy.

Dear Dr. Roach: Yesterday, my right hand started shaking uncontrollably. It did not stop for two hours. My left hand has had issues for years, shaking mostly when reading the paper or holding ...

People with epilepsy are at risk for hypertension, atrial fibrillation, and hyperlipidemia; they also have an elevated risk ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Valproate (Depakene) emerged as the best first-line choice for ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, ...